The US Food and Drug Administration (FDA) has created a Digital Health Advisory Committee to assist with the complexities of digital health technologies. The committee will offer expertise to improve the FDA’s grasp of the benefits, risks and clinical results from using technologies such as AI, digital therapeutics and wearables. The committee, expected to be fully operational by 2024, will also ensure that digital medical devices are suitable for varied populations.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
